TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Investing

    3 Companies Actually Investing in the Future

    While analysts at the Bank of Canada and big banks such as Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM) are seeing…

    Read more »

    The Motley Fool
    Dividend Stocks

    Brexit: 4 Negative Effects on the Stock Market

    The Brexit added volatility to the stock market, but selective groups of stocks are more vulnerable to declines, including cyclical…

    Read more »

    The Motley Fool
    Investing

    Can Investors Expect Anything Good From Valeant Pharmaceuticals Intl Inc.?

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) won't default, it needs to show that it can be profitable and pay down…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Recover?

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) tumbled this week on reports that it cut 2016 profit forecasts, prompting investors…

    Read more »

    The Motley Fool
    Investing

    3 TSX Stocks That Are Down but Not out

    There are 32 TSX stocks down at least 5% year-to-date, including Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), which is off a…

    Read more »

    The Motley Fool
    Investing

    Has the Worst Passed for Valeant Pharmaceuticals Intl Inc.?

    After what can only be described as an epic collapse, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:NRX) may have turned the first…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is It Going to Default?

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) received a default notice, I expect it to be just fine, and it might…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Cleans Shop. Is it a Buy Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is looking to turn around with operational changes. However, it's not a buy until it…

    Read more »

    The Motley Fool
    Energy Stocks

    Will These 3 Struggling Stocks Survive 2016?

    This year could be fatal for Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE), Sears Canada Inc. (TSX:SCC), and Valeant Pharmaceuticals Intl Inc.…

    Read more »

    The Motley Fool
    Investing

    Good News for Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) gets some good news on its CEO search.

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still an Option?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been through considerable controversy over the past few months, raising concerns about whether or…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is a Buy if its Parts Sell

    Until Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) sells some of its business and pays down debt, investors should still avoid it.…

    Read more »